vs
Side-by-side financial comparison of Blue Foundry Bancorp (BLFY) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $13.3M, roughly 1.3× Blue Foundry Bancorp). Blue Foundry Bancorp runs the higher net margin — -27.4% vs -64.3%, a 36.9% gap on every dollar of revenue. On growth, Blue Foundry Bancorp posted the faster year-over-year revenue change (34.2% vs 24.5%).
Blue Foundry Bancorp is a regional bank holding company based in New Jersey, United States. It offers a comprehensive range of personal and commercial banking products, including deposit accounts, consumer loans, mortgage services, and business financing solutions, serving local individual consumers and small to medium-sized enterprises.
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
BLFY vs IVVD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $17.2M |
| Net Profit | $-3.5M | $-11.1M |
| Gross Margin | — | — |
| Operating Margin | — | -73.0% |
| Net Margin | -27.4% | -64.3% |
| Revenue YoY | 34.2% | 24.5% |
| Net Profit YoY | -30.6% | 40.0% |
| EPS (diluted) | $-0.18 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $17.2M | ||
| Q3 25 | $12.6M | $13.1M | ||
| Q2 25 | $12.0M | $11.8M | ||
| Q1 25 | $11.1M | $11.3M | ||
| Q4 24 | $9.9M | $13.8M | ||
| Q3 24 | $9.5M | $9.3M | ||
| Q2 24 | $10.1M | $2.3M | ||
| Q1 24 | $9.9M | $0 |
| Q4 25 | $-3.5M | $-11.1M | ||
| Q3 25 | $-1.9M | $-10.5M | ||
| Q2 25 | $-2.0M | $-14.7M | ||
| Q1 25 | $-2.7M | $-16.3M | ||
| Q4 24 | $-2.7M | $-18.4M | ||
| Q3 24 | $-4.0M | $-60.7M | ||
| Q2 24 | $-2.3M | $-47.2M | ||
| Q1 24 | $-2.8M | $-43.5M |
| Q4 25 | — | -73.0% | ||
| Q3 25 | — | -84.0% | ||
| Q2 25 | — | -127.8% | ||
| Q1 25 | — | -149.7% | ||
| Q4 24 | — | -139.1% | ||
| Q3 24 | — | -670.0% | ||
| Q2 24 | — | -2175.2% | ||
| Q1 24 | — | — |
| Q4 25 | -27.4% | -64.3% | ||
| Q3 25 | -14.8% | -79.7% | ||
| Q2 25 | -16.2% | -124.4% | ||
| Q1 25 | -24.2% | -144.1% | ||
| Q4 24 | -28.4% | -133.5% | ||
| Q3 24 | -42.7% | -653.1% | ||
| Q2 24 | -23.2% | -2086.9% | ||
| Q1 24 | -28.8% | — |
| Q4 25 | $-0.18 | $0.02 | ||
| Q3 25 | $-0.10 | $-0.06 | ||
| Q2 25 | $-0.10 | $-0.12 | ||
| Q1 25 | $-0.13 | $-0.14 | ||
| Q4 24 | $-0.12 | $-0.14 | ||
| Q3 24 | $-0.19 | $-0.51 | ||
| Q2 24 | $-0.11 | $-0.40 | ||
| Q1 24 | $-0.13 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.1M | $226.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $312.7M | $241.5M |
| Total Assets | $2.2B | $276.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.1M | $226.7M | ||
| Q3 25 | $44.1M | $85.0M | ||
| Q2 25 | $41.9M | $34.9M | ||
| Q1 25 | $46.2M | $48.1M | ||
| Q4 24 | $42.5M | $69.3M | ||
| Q3 24 | $76.1M | $106.9M | ||
| Q2 24 | $60.3M | $147.9M | ||
| Q1 24 | $53.8M | $189.4M |
| Q4 25 | $312.7M | $241.5M | ||
| Q3 25 | $314.4M | $93.1M | ||
| Q2 25 | $321.3M | $42.8M | ||
| Q1 25 | $326.7M | $54.1M | ||
| Q4 24 | $332.2M | $67.5M | ||
| Q3 24 | $339.3M | $83.2M | ||
| Q2 24 | $345.6M | $140.6M | ||
| Q1 24 | $350.2M | $178.5M |
| Q4 25 | $2.2B | $276.9M | ||
| Q3 25 | $2.2B | $139.2M | ||
| Q2 25 | $2.1B | $89.1M | ||
| Q1 25 | $2.1B | $103.7M | ||
| Q4 24 | $2.1B | $129.5M | ||
| Q3 24 | $2.1B | $161.9M | ||
| Q2 24 | $2.0B | $177.3M | ||
| Q1 24 | $2.0B | $215.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.0M | $-15.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.0M | $-15.5M | ||
| Q3 25 | $-255.0K | $-8.3M | ||
| Q2 25 | $2.0M | $-13.3M | ||
| Q1 25 | $-3.8M | $-21.1M | ||
| Q4 24 | $5.1M | $-37.6M | ||
| Q3 24 | $-3.7M | $-41.1M | ||
| Q2 24 | $14.1M | $-41.6M | ||
| Q1 24 | $-4.9M | $-50.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-13.3M | ||
| Q1 25 | — | $-21.3M | ||
| Q4 24 | $4.9M | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | $-4.9M | $-50.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -112.9% | ||
| Q1 25 | — | -188.2% | ||
| Q4 24 | 49.8% | -272.2% | ||
| Q3 24 | — | -441.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | -49.3% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | 1.4% | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 0.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
